Bisphosphonates: Advances in Research and Application: 2011 Edition: ScholarlyPaper
ScholarlyEditions, Jan 9, 2012 - Medical - 20 pages
Bisphosphonates: Advances in Research and Application: 2011 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Bisphosphonates in a compact format.
The editors have built Bisphosphonates: Advances in Research and Application: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Bisphosphonates in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Bisphosphonates: Advances in Research and Application: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility.
What people are saying - Write a review
Comparison of monthly ibandronate versus weekly risedronate in preference convenience and bone turnover markers in Korean postmenopausal ost...
Evaluation of a novel osteoporotic drug delivery system in vitro alendronateloaded calcium phosphate cement
Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats
The role of zoledronic acid in the adjuvant treatment of breast cancer current perspectives
Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after longterm alendronate treatment qBEI and sSAXS ...
In vitro osteogenesis of synovium mesenchymal cells induced by controlled release of alendronate and dexamethasone from a sintered microspherica...
Sustained vertebral antifracture efficacy of oral antiosteoporotic therapies in postmenopausal osteoporosis
Osteogenic activity of locally applied small molecule drugs in a rat femur defect model
Prevention of aromatase inhibitorinduced bone loss using risedronate the SABRE trial
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase2 gene upregulation